Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07222774 · ClinicalTrials.gov registry record · NA

Strengthening Intentions

A NA study of Influenza Vaccination and Behavior And Behavior Mechanism, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT07222774: Active NA study of Influenza Vaccination and Behavior And Behavior Mechanism, sponsored by University of Pennsylvania.

NCT07222774 is a NA study of Influenza Vaccination and Behavior And Behavior Mechanism that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 350 participants, below the 37,757-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07222774, a NA study of Influenza Vaccination and Behavior And Behavior Mechanism, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

participants are randomized to a study arm that measures intention to perform a health related behavior and follows up to measure behavior

Primary Outcome

whether behavior was performed

Interventions

  • BEHAVIORAL Experimental

Study Locations (1)

Pennsylvania

  • Penn Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2025-10-15
Est. Completion 2027-12-01
Phase NA
University of Pennsylvania

1,423 total trials

What the registry record for NCT07222774 still lists

NCT07222774 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 37,757-participant average among 3 other Influenza Vaccination trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Influenza Vaccination appearing as the primary indexed condition, and to 1 intervention - of which Experimental is the first listed.

NCT07222774 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07222774 about?

NCT07222774 is a clinical study titled "Strengthening Intentions". participants are randomized to a study arm that measures intention to perform a health related behavior and follows up to measure behavior

What is the current status of trial NCT07222774?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2025-10-15. Estimated completion is 2027-12-01.

What conditions does trial NCT07222774 study?

This clinical trial studies the following conditions: Influenza Vaccination, Behavior And Behavior Mechanism.

What interventions are being tested in trial NCT07222774?

The interventions under investigation include: Experimental (BEHAVIORAL).

Who is sponsoring clinical trial NCT07222774?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07222774 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza Vaccination

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07222774, the US trial registry maintained by the National Library of Medicine. NCT07222774 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.